Transatlantic Taskforce on Antimicrobial Resistance (TATFAR)

TATFAR was created in 2009 to address the urgent threat of antimicrobial resistance (AMR). TATFAR’s technical experts from Canada, the European Union (EU), Norway, the United Kingdom (U.K.) and the United States (U.S.) collaborate and share best practices to strengthen domestic and global efforts.

CDC currently serves as the secretariat for TATFAR, providing administrative support and maintaining the website for the Taskforce.

Key Areas of Focus to Reduce the Threat of AMR
  • Appropriate antimicrobial use in human and veterinary medicine
  • Surveillance and prevention of AMR
  • Strategies to improve financial incentives, access, research, and development of antimicrobial drugs, diagnostics, and alternatives
  • Cross-cutting actions to improve awareness and disseminate information from TATFAR
In September 2021, the Taskforce welcomed the U.K., another global leader in the fight against AMR, as its newest member.
Update on Work Plan

TATFAR members developed and approved a new work plan for the 2021-2026 implementation period. The 2016-2020 Progress Report [PDF – 47 Pages] is now available.

Contact the CDC TATFAR Liaison

Antibiotic Resistance Coordination and Strategy Unit
Centers for Disease Control and Prevention
1600 Clifton Road NE, MS C-12
Phone: 800-CDC-INFO – (800-232-4636)